Achieving that goal requires careful planning along with bold creativity, focus as well as flexibility in following where the science leads. Through our centerwide strategic planning process, we have identified the following priority objectives.
We are accelerating our high-impact, interdisciplinary science in the areas of:
Because lifesaving team science doesn’t happen in a vacuum, we support those scientific priorities through culture, infrastructure and partnerships and clinical excellence focused on mission above all else.
A diverse, inclusive, high-performance culture is essential to ending cancer and related diseases. We’re investing in our dedicated and talented people to enable them to excel in realizing our ambitious vision.
From our state-of-the-art campus and core shared resources to the Hutch Data Commonwealth, we are continuously enhancing the infrastructure that underpins discovery.
To multiply our impact and extend the reach of our advances, we are cultivating productive partnerships, including with philanthropic supporters, research and industry colleagues, and public policy leaders and lawmakers.
With our Fred Hutch/University of Washington Cancer Consortium partners, we strive to develop and deliver the best possible cancer care. World-class clinical oncology programs help us translate our discoveries into improvements for patients, including through clinical trials. They also drive new discoveries by helping us recruit outstanding translational and clinical scientists, and enabling our researchers to develop and test new hypotheses.